Liver Diseases  >>  Selzentry (maraviroc)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Selzentry (maraviroc) / ViiV Healthcare
MARACON, NCT01736813: CCR5-blockade in Metastatic Colorectal Cancer

Completed
1
12
Europe
Maraviroc, Celsentri
National Center for Tumor Diseases, Heidelberg, University Hospital Heidelberg
Colorectal Cancer, Neoplasm Metastasis, Liver Metastases
12/13
09/14

Download Options